# Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure

> **NCT06786208** · — · NOT_YET_RECRUITING · sponsor: **Henan Cancer Hospital** · enrollment: 55 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Sunvozertinib

## Key facts

- **NCT ID:** NCT06786208
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06786208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06786208, "Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06786208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*